Tower Research Capital LLC (Trc) Cns Pharmaceuticals, Inc. Transaction History

Tower Research Capital LLC (Trc)

  • $5.8 Billion
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 10, 2022
BUY
$0.19 - $292.65 $1,048 - $1.62 Million
5,519 Added 19.03%
34,526 $6,000
Q2 2022

Aug 15, 2022
BUY
$0.26 - $0.43 $151 - $250
582 Added 2.05%
29,007 $8,000
Q1 2022

May 12, 2022
BUY
$0.26 - $1.05 $3,843 - $15,522
14,783 Added 108.36%
28,425 $10,000
Q4 2021

Feb 14, 2022
BUY
$0.7 - $1.54 $9,549 - $21,008
13,642 New
13,642 $10,000

Others Institutions Holding CNSP

# of Institutions
1
Shares Held
100
Call Options Held
0
Put Options Held
0
View Full List

About CNS Pharmaceuticals, Inc.

CNSP Quotes by TradingView
  • Ticker CNSP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 40,032,500
  • Market Cap $4.4M
  • Description
  • CNS Pharmaceuticals, Inc., a clinical pharmaceutical company, engages in the development of anti-cancer drug candidates for the treatment of brain and central nervous system tumors. The company's lead drug candidate is Berubicin, an anthracycline that is in Phase I and II clinical trials that is used for the treatment of glioblastoma multiforme....
More about CNSP
Track This Portfolio

Track Tower Research Capital LLC (Trc) Portfolio

Follow Tower Research Capital LLC (Trc) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email